Earnings History Data for Aileron Therapeutics, Inc. (ALRN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aileron Therapeutics, Inc.

Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers which are in clinical stage. Aileron Therapeutics, Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-11-2022	PM		ALRN	Aileron Therapeutics	18.00	-0.07	-0.08	0.00	Aileron Therapeutics GAAP EPS of -$0.07 beats by $0.01 [11/1/2022 8:41 AM]	0.2050	0.0 (2.50%)	0.20	0.0 (0.00%)	0.13 - 0.94	153,213	250,000	100
Aileron Therapeutics GAAP EPS of -$0.07 beats by $0.01 [11/1/2022 8:41 AM] Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights [Nov-01-22 08:15AM]
15-08-2022	AH		ALRN	Aileron Therapeutics	20.00	-0.09	-0.09	0.00	Aileron Therapeutics GAAP EPS of -$0.09 [8/15/2022 5:29 PM]	0.2287	0.01 (6.92%)	0.22	0.0 (2.06%)	0.13 - 1.27	769,203	2,740,000	9,935
Aileron Therapeutics GAAP EPS of -$0.09 [8/15/2022 5:29 PM] Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights [Aug-15-22 04:15PM]
05-05-2022	AH	4:20 PM ET (May 5)	ALRN	Aileron Therapeutics	38.00	-0.09	-0.08	0.00	Aileron Therapeutics GAAP EPS of -$0.09 misses by $0.01 [5/5/2022 5:15 PM]	0.43	0.0 (-0.58%)	0.43	0.0 (-0.58%)	0.36 - 1.40	212,063	290,000	162
Aileron Therapeutics GAAP EPS of -$0.09 misses by $0.01 [5/5/2022 5:15 PM] Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights [May-05-22 04:15PM]
12-11-2021	PM		ALRN	Aileron Therapeutics, Inc.	83.31	-0.07	-0.07	-0.13	Aileron Therapeutics EPS in-line [11/12/2021 7:57 AM]	0.8699	-0.06 (-5.95%)	0.92	0.0 (0.00%)	0.85 - 2.33	560,269	290,000	13,456
Aileron Therapeutics EPS in-line [11/12/2021 7:57 AM] Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights [Nov-12-21 07:50AM]
11-05-2021	AH	4:35 PM ET (May 11)	ALRN	Aileron Therapeutics, Inc.	100.23	-0.08	-0.05	-0.24	Aileron Therapeutics EPS misses by $0.02 [5/11/2021 4:40 PM]	1.17	0.04 (3.54%)	1.12	-0.01 (-0.88%)	0.55 - 2.47	582,978	680,000	7,045
Aileron Therapeutics EPS misses by $0.02 [5/11/2021 4:40 PM] Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update [May-11-21 04:18PM]
12-11-2020	AH		ALRN	Aileron Therapeutics, Inc.	44.26	-0.13	-0.10	-0.28	Aileron Therapeutics EPS in-line [11/12/2020 10:28 PM]	1.06	-0.02 (-1.40%)	1.08	0.01 (0.93%)	0.25 - 2.47	449,998	630,170	1,781